214 related articles for article (PubMed ID: 7536999)
1. [Prostacyclin (iloprost) as an adjuvant in local surgical therapy of stage IV arterial occlusive disease--is quantification of the therapeutic effect possible with tcPO2 measurements?].
Breuer C; Abri O
Vasa; 1995; 24(1):62-71. PubMed ID: 7536999
[TBL] [Abstract][Full Text] [Related]
2. Low-dose iloprost infusions compared to the standard dose in patients with peripheral arterial occlusive disease Fontaine stage IV. DAWID Study Group.
Beischer W; Dembski JC; Gruss JD; Hofgärtner F; Horsch A; Horsch S; Kuhlmann HW; Loose DA; Mietaschk A; Schwilden ED; Spengel F; Spitzer W; Staben P; Stallkamp B; Stürzebecher CS; Tokhi M; von Bilderling P
Vasa; 1998 Feb; 27(1):15-9. PubMed ID: 9540427
[TBL] [Abstract][Full Text] [Related]
3. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
Claeys LG; Horsch S
Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the amputation level by transcutaneous PO2 measurement and distal arterial systolic pressure].
Depairon M; Krahenbuhl B; Vaucher J
J Mal Vasc; 1986; 11(3):229-34. PubMed ID: 3772253
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of transcutaneous oxygen tension (TcPO2) measurement in the testing period of spinal cord stimulation in diabetic patients with critical lower limb ischaemia.
Petrakis E; Sciacca V
Int Angiol; 2000 Mar; 19(1):18-25. PubMed ID: 10853681
[TBL] [Abstract][Full Text] [Related]
6. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
[TBL] [Abstract][Full Text] [Related]
7. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
Petrakis IE; Sciacca V
Int Surg; 1999; 84(2):122-8. PubMed ID: 10408282
[TBL] [Abstract][Full Text] [Related]
8. [Value of measuring transcutaneous oxygen pressure in arterial disease of the legs].
Becker F; Gabrielle F; Raoux MH; Brenot R; David M
Ann Cardiol Angeiol (Paris); 1989 Oct; 38(8):465-72. PubMed ID: 2596817
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with peripheral arterial occlusive disease Fontaine stage III and IV with intravenous iloprost: an open study in 900 patients.
Staben P; Albring M
Prostaglandins Leukot Essent Fatty Acids; 1996 May; 54(5):327-33. PubMed ID: 8832761
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements.
Bacharach JM; Rooke TW; Osmundson PJ; Gloviczki P
J Vasc Surg; 1992 Mar; 15(3):558-63. PubMed ID: 1538514
[TBL] [Abstract][Full Text] [Related]
11. Application of transcutaneous oxymetry in vascular surgery.
Szala K; Kostewicz W; Noszczyk W
Int Angiol; 1988; 7(4):301-4. PubMed ID: 3243984
[TBL] [Abstract][Full Text] [Related]
12. Prognostic aspects of TcPO2 in iloprost treatment as an alternative to amputation.
Chomard D; Habault P; Ledemeney M; Haon C
Angiology; 1999 Apr; 50(4):283-8. PubMed ID: 10225463
[TBL] [Abstract][Full Text] [Related]
13. Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculation.
Caspary L; Creutzig A; Alexander K
Eur J Clin Pharmacol; 1991; 41(2):131-6. PubMed ID: 1720738
[TBL] [Abstract][Full Text] [Related]
14. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
[TBL] [Abstract][Full Text] [Related]
15. Predicting amputation in severe ischaemia. The value of transcutaneous PO2 measurement.
Bongard O; Krähenbühl B
J Bone Joint Surg Br; 1988 May; 70(3):465-7. PubMed ID: 3372572
[TBL] [Abstract][Full Text] [Related]
16. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
[TBL] [Abstract][Full Text] [Related]
17. Healing of open stump wounds after vascular below-knee amputation: plaster cast socket with silicone sleeve versus elastic compression.
Vigier S; Casillas JM; Dulieu V; Rouhier-Marcer I; D'Athis P; Didier JP
Arch Phys Med Rehabil; 1999 Oct; 80(10):1327-30. PubMed ID: 10527096
[TBL] [Abstract][Full Text] [Related]
18. Determination of amputation level in ischaemic limbs using tcPO2 measurement.
Poredos P; Rakovec S; Guzic-Salobir B
Vasa; 2005 May; 34(2):108-12. PubMed ID: 15968892
[TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of transcutaneous oximetry (tcPO2) during oxygen inhalation and leg dependency in severe peripheral arterial occlusive disease.
Scheffler A; Rieger H
J Vasc Surg; 1992 Aug; 16(2):218-24. PubMed ID: 1495145
[TBL] [Abstract][Full Text] [Related]
20. Tolerance of Iloprost and results of treatment of chronic severe lower limb ischaemia in diabetic patients. A retrospective study of 64 consecutive cases.
Duthois S; Cailleux N; Benosman B; Lévesque H
Diabetes Metab; 2003 Feb; 29(1):36-43. PubMed ID: 12629446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
